Roles - Tasks of Partners

The consortium includes partners from academic institutions and hospitals. The partnership accounts for technology provision and project management by the Lab of Medical Informatics of the Aristotle University of Thessaloniki (AUTH-LP1) and for medical services, research and analysis and capitalisation of results by all partners: a. The 2nd Pediatrics Clinic of AUTH (LP1), b. The Clinical Hospital “Dr. Trifun Panovski” Bitola (LP2), c. The Giannitsa General Hospital (PP3), d. The Florina General Hospital (PP4), e. The Health Home Gevgelija (PP5).
Project Management will be led by AUTH, while all partners will contribute by participating to coordination meetings and providing information for progress/financial monitoring. WP2 will also be addressed by all partners through awareness-raising on children health and dissemination of project outcomes and results in conferences and media.
In WP3 AUTH will offer its extensive expertise for the research on state of the art technologies that
will be developed within the project, and on medical factors associated with obesity and cardiovascular diseases. Other partners will also contribute in WP3 by undertaking preparatory activities and planning of the blood samplings in their respective areas (Pelagonia, Pella, Florina, Southeast) through coordinating activities with education boards and organizing preparatory seminars for the target groups of the project. Besides, all partners will make all necessary arrangements for purchasing of the necessary consumables  and kits for ELISA, biochemical and genetic analysis and the infrastructure to maintain the collected samples such as  freezers.
WP4 involves the blood samplings of all partners in their respective areas. Hospitals have the necessary personnel and expertise to address ethical and safety issues and perform the blood samplings in a trustful manner. The number of samplings will be equivalent to the overall children population of the regions. Priority will be given (if volunteer children exceed the capacity of the project) to high-risk children, e.g. obese or with family CVD history. However, Action 4.2. will only be addressed by LP1 which has the necessary infrastructure (funded by a previous cross-border collaboration project) to perform  the required clinical and genetics analysis.
WP5 will be addressed by LP1 with the involvement and cooperation of all medical professionals from all partners who will participate in software design and will perform testings of the system prototypes in order to address problems and deficiencies.
In WP6, Actions 6.1 and 6.2 involve the integration of the system with the results of the biochemical analysis and will be performed by AUTH. Actions 6.3., 6.4. and 6.5. will be collaboratively addressed by all clinicians, who will be engaged in the development of educational material, in educating professionals and in the exploitation of the project results.